Stockreport

Context Therapeutics to Participate in Upcoming Investor Conferences

Context Therapeutics Inc.  (CNTX) 
PDF PHILADELPHIA, Feb. 09, 2026 (GLOBE NEWSWIRE) -- Context Therapeutics Inc. (“Context” or the “Company”) (Nasdaq: CNTX), a clinical-stage biopharmaceutical company advan [Read more]